Home
/
Hepion Pharmaceuticals, Inc.
/
Financials
/
Quarterly
Hepion Pharmaceuticals, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Hepion Pharmaceuticals, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q1
2024
Mar 31, 2024
$0
May 21, 2024
Q3
2023
Sep 30, 2023
$0
Nov 20, 2023
Q2
2023
Jun 30, 2023
$0
Aug 14, 2023
Q1
2024
Mar 31, 2023
$0
May 21, 2024
Q3
2023
Sep 30, 2022
$0
Nov 20, 2023
Q2
2023
Jun 30, 2022
$0
Aug 14, 2023
Q1
2023
Mar 31, 2022
$0
May 12, 2023
Q3
2022
Sep 30, 2021
$0
Nov 14, 2022
Q2
2022
Jun 30, 2021
$0
Aug 15, 2022
Q1
2022
Mar 31, 2021
$0
May 16, 2022
Q3
2021
Sep 30, 2020
$0
Nov 15, 2021
Q2
2021
Jun 30, 2020
$0
Aug 16, 2021
Q1
2021
Mar 31, 2020
$0
May 14, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($472.5K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($1.04M)
Aug 14, 2025
Q3
2025
Jun 30, 2025
($1.04M)
Nov 12, 2025
Q3
2025
Mar 31, 2025
($6.11M)
Nov 12, 2025
Q1
2025
Mar 31, 2025
($6.11M)
May 19, 2025
Q2
2025
Mar 31, 2025
($6.11M)
Aug 14, 2025
Q3
2025
Sep 30, 2024
($4.87M)
Nov 12, 2025
Q3
2025
Jun 30, 2024
($3.93M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($3.93M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($2.85M)
May 19, 2025
Q2
2025
Mar 31, 2024
($2.85M)
Aug 14, 2025
Q3
2025
Mar 31, 2024
($2.85M)
Nov 12, 2025
Q3
2024
Sep 30, 2023
($10.53M)
Nov 14, 2024
Q3
2024
Jun 30, 2023
($14.08M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($14.08M)
Aug 13, 2024
Q3
2024
Mar 31, 2023
($13.26M)
Nov 14, 2024
Q2
2024
Mar 31, 2023
($13.26M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($13.26M)
May 21, 2024
Q3
2023
Sep 30, 2022
($8.55M)
Nov 20, 2023
Q3
2023
Jun 30, 2022
($19.91M)
Nov 20, 2023
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($527.9K)
Nov 12, 2025
Q2
2025
Jun 30, 2025
($1.75M)
Aug 14, 2025
Q1
2025
Mar 31, 2025
($1.28M)
May 19, 2025
Q3
2025
Sep 30, 2024
($4.46M)
Nov 12, 2025
Q2
2025
Jun 30, 2024
($8.50M)
Aug 14, 2025
Q1
2025
Mar 31, 2024
($5.18M)
May 19, 2025
Q3
2024
Sep 30, 2023
($10.66M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($14.17M)
Aug 13, 2024
Q1
2024
Mar 31, 2023
($13.21M)
May 21, 2024
Q3
2023
Sep 30, 2022
($8.47M)
Nov 20, 2023
Q2
2023
Jun 30, 2022
($20.00M)
Aug 14, 2023
Q1
2023
Mar 31, 2022
($7.25M)
May 12, 2023
Q3
2022
Sep 30, 2021
($8.52M)
Nov 14, 2022
Q2
2022
Jun 30, 2021
($6.85M)
Aug 15, 2022
Q1
2022
Mar 31, 2021
($6.03M)
May 16, 2022
Q3
2021
Sep 30, 2020
($6.23M)
Nov 15, 2021
Q2
2021
Jun 30, 2020
($4.78M)
Aug 16, 2021
Q1
2021
Mar 31, 2020
($4.19M)
May 14, 2021
Q3
2020
Sep 30, 2019
($1.91M)
Nov 16, 2020
Q2
2020
Jun 30, 2019
($1.70M)
Aug 12, 2020